Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$3.65M | -$4.95M |
| EPS Diluted | -$0.08 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 9, 2011 · 40 d after period end
